Évaluation économique de la thérapie cognitivo-comportementale des troubles anxieux

Canadian Psychology

Volumn 45, Issue 3, 2004, Pages 202-218

  Roberge, Pasquale ^a   Marchand, André ^a   Reinharz, Daniel ^b   Marchand, Lyne ^a   Cloutier, Karine ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4043123835     PISSN: 07085591     EISSN: None     Source Type: Journal    
DOI: 10.1037/h0086988     Document Type: Review

References (97)

1. Antony, M. M. (1997). Assessment and treatment of social phobia. Canadian Journal of Psychiatry, 42, 826-834.
2. Antony, M. M., & Barlow, D. H. (2002). Specific Phobias. Dans D. H. Barlow (Ed.), Anxiety and its disorders: The nature and treatment of anxiety and panic (2e éd.) (p. 380-417). NewYork: Guilford.
3. Antony, M. M., & Swinson, R. P. (1996). Les troubles anxieux et leur traitement: analyse critique de la littérature sur les traitements fondés sur des preuves. Ottawa, ON: Publications Santé Canada.
4. Ballenger, J. C. (1997). Panic disorder in the medical setting. Journal of Clinical Psychiatry, 55(2), 13-17.
5. Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y., Nutt, D. J., Borkovec, T. D., Rickels, K., & al. (2001). Consensus statement on generalized anxiety disorder from the International consensus group on depression and anxiety. Journal of Clinical Psychiatry, 62(11), 53-58.
6. Barlow, D. H. (1997). Cognitive-behavioral therapy for panic disorder: Current status. Journal of Clinical Psychiatry, 58(2), 32-36.
7. Barlow, D. H., Esler, J. L., & Vitali, A. E. (1998). Psychosocial treatments for panic disorders, phobias, and generalized anxiety disorder. Dans P. E. Nathan, & J. M. Gorman (Éds.), A guide to treatments that work (p. 288-299). New York: Oxford University Press.
8. Borkovec, T. D., & Ruscio, A. M. (2001). Psychotherapy for generalized anxiety disorder. Journal of Clinical Psychiatry, 62(11), 37-42.
9. Bowen, R. C., D'Arcy, C., South, M. N., & Hawkes, J. E. (1990). The effects of a nurse therapist conducted behavioral agoraphobia treatment program on medical utilization. Journal of Anxiety Disorders, 4, 341-349.
10. Brady, K. T., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., & Sikes, C. R. (2000). Efficacy and safety of sertraline treatment of posttraumatic disorder: A randomized controlled trial. Journal of the American Medical Association, 28, 563-564.
11. Buller, R., Winter, P., Amering, M., Katschnig, H., Lavori, P. W., Deltito, J. A., & al. (1992). Center differences and cross-national invariance in help-seeking for panic disorder: A report from the cross-national collaborative panic study, Social Psychiatry and Psychiatric Epidemiology, 27, 135-141.
12. Butler, G., Fennell, M., Robson, P., & Gelder, M. (1991). Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 59, 167-175.
13. Chambless, D. L., & Gillis, M. M. (1993). Cognitive therapy of anxiety disorders. Journal of Consulting and Clinical Psychology, 61, 248-260.
14. Clark, D. M., & Salkovkis, P. M. (1989). Cognitive therapy for panic and hypochondriasis. Oxford: Pergamon Press.
15. Clum, G. A., Glum, G. A., & Surls, R. (1993). A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology, 61, 317-326.
16. Cottraux, J., Mollard, E., Bouvard, M., & Marks, I. (1993). Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: One year follow-up. Psychiatric Research, 49, 63-75.
17. Cottraux, J., Mollard, E., Bouvard, M., Marks, I., Sluys, M., Nury, A. M., et al. (1990). A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmacology, 5, 17-30.
18. Craske, M. G., & Barlow, D. H. (2001). Panic disorder and agoraphobia. Dans D. H. Barlow, Clinical handbook of psychological disorders (3e éd.). New York: Guilford.
19. Davidson, J. (2000). Pharmacotherapy of posttraumatic stress disorder: Treatment options, long term follow-up, and predictors of outcome. Journal of Clinical Psychiatry, 61(5), 52-56.
20. Davidson, J., Kudler, H., Smith, R., Mahorney, S. L., Lipper, S., Hammett, E., & al. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259-266.
21. Drummond, M. F., O'Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health-care programmes (2e éd.). New York: Oxford University Press.
22. Dupont, R. L., Rice, D. P., Miller, L. S., Shiraki, S. S., Rowland, C. R., & Harwood, H. J. (1996). Economic costs of anxiety disorders. Anxiety, 2, 167-172.
23. Ettigi, P., Meyerhoff, A. S., Chirban, J. T., Jacobs, R. J., & Wilson, R. R. (1997). The quality of life and employment in panic disorder. Journal of Nervous and Mental Disease, 185, 368-372.
24. Evers, S. M. A. A., Van Wijk, A. S., & Ament, A. J. H. A. (1997). Economic evaluation of mental health-care interventions. A review. Health Economics, 6, 161-177.
25. Fedoroff, I. C., & Taylor, S. (2001). Psychological and pharmacological treatments of social phobia: A meta-analysis. Journal of Clinical Psychopharmacology, 21, 311-24.
26. Foa, E. B., & Kozak, M. J. (1996). Psychological treatment for obsessive-compulsive disorder. Dans M. R. Mavissakalian & R. F. Prien (Éds.), Long-term treatments of anxiety disorders, (p. 285-309). Washington, DC: American Psychiatric Press.
27. Friedman, M. J. (2000). Posttraumatic Stress Disorder: The latest assessment and treatment strategies. Kansas City, MO: Clinical Compacts.
28. Friedman, R., Sobel, D., Myers, P., Caudill, M., & Benson, H. (1995). Behavioral medicine, clinical health psychology, and cost offset. Health Psychology, 14, 509-518.
29. Gabbard, G. O., Lazar, S. G., Hornberger, J., & Spiegel, D. (1997). The economic impact of psychotherapy: A review. American Journal of Psychiatry, 154, 147-155.
30. Ginzberg, E. (1987). Psychiatry before the year 2000: The long view. Hospital and Community Psychiatry, 38, 725-728.
31. Gorman, J. M. (2003). Treating generalized anxiety disorder. Journal of Clinical Psychiatry, 64(2), 24-29.
32. Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. W., & Yap, L. (1997). Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clinical Psychology: Science and Practice, 4, 291-306.
33. Gould, R. A., Otto, M. W., & Pollack, M. H. (1995). A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review, 15, 819-844.
34. Gould, R. A., Otto, M. W., Pollack, M. H., & Yap, L. (1997). Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behavior therapy, 28, 285-305.
35. Greist, J. H. (1998). The comparative effectiveness of treatments for obsessive-compulsive disorder. Bulletin of the Menninger Clinic, 62(4A), A65-A81.
36. Hofmann, S. G., & Barlow, D. H. (1999). The costs of anxiety disorders: Implications for psychosocial interventions. Dans N. E. Miller & K. M. Magruder (Éds.), Cost-effectiveness of psychotherapy (p. 224-234). New York: Oxford University Press.
37. Jaycox, L. H., & Foa, E. B. (1999). Cost-effectiveness issues in the treatment of posttraumatic stress disorder. Dans N. E. Miller & K. M. Magruder (Éds.), Cost-effectiveness of psychotherapy (p. 259-269). New York: Oxford University Press.
38. Juster, H. R., & Heimberg, R. G. (1995). Social phobia. Longitudinal course and long-term outcome of cognitive-behavioral treatment. Psychiatric Clinics of North America, 18, 821-842.
39. Kashner, T. M., & Rush, A. J. (1999). Measuring medical offsets of psychotherapy. Dans N. E. Miller & K. M. Magruder (Éds.), Cost-effectiveness of psychotherapy (p. 109-121). New York: Oxford University Press.
40. Katon, W. (1996). Panic disorder: Relationship to high medical utilization, unexplained physical symptoms, and medical costs. Journal of Clinical Psychiatry, 57(10), 11-18.
41. Katon, W. J., Von Korff, M., & Lin, E. (1992). Panic Disorder: Relationship to high medical utilization. American Journal of Medicine, 92(1A), 7S-11S.
42. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hugues, M., Eshleman, S., & al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19.
43. Klerman, G. L., Weissman, M. M., Ouellette, R., Johnson, J., & Greenwald, S. (1991). Panic attacks in the community: Social morbidity and health-care utilization. Journal of the American Medical Association, 265, 742-746.
44. Kobak, K. A., Greist, J. H., Jefferson, J. W., Katzelnick, D. J., & Henk, H. J. (1998). Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis. Psychopharmacology, 136, 205-216.
45. Kosten, T. R., Frank, J. B., Dan, E., McDougle, C. J., & Giller, E. L.,Jr. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366-370.
46. Leon, A. C., Portera, L., & Weissman, M. M. (1995). The social costs of anxiety disorders. British Journal of Psychiatry, 166(27), 19-22.
47. Logue, M. B., Thomas, A. M., Barbee, J. G., Hoehn-Saric, R., Maddock, R. J., Schwab, J., et al. (1993). Generalized anxiety disorder patients seek evaluation for cardiological symptoms at the same frequency as patients with panic disorder. Journal of Psychiatric Research, 27, 55-59.
48. Marchand, A., & Boivin, I. (1999). Le trouble panique. Dans R. Ladouceur, A. Marchand & J. M. Boisvert (Éds.), Les troubles anxieux: approche cognitive et comportementale. Montréal, QC: Gaétan Morin.
49. Marchand, A., & Brillon, P. (1999). Le trouble de stress post-traumatique. Dans R. Ladouceur, A. Marchand & J. M. Boisvert (Eds.), Les troubles anxieux: approche cognitive et comportementale, Montréal, QC: Gaétan Morin.
50. Marchand, A., Comeau, S., & Trudel, G. (1994). L'influence de la relation conjugale dans le développement, le maintien et le traitement du trouble panique avec agoraphobie. Thérapie comportementale et cognitive, 4(3), 76-88.
51. Marchand, A., Roberge, P., Dupuis, G., Contandriopoulos, A. P., Mainguy, N., & Savard, P. (2000). Évaluation clinique, psychosociale et économique de trois modalités de traitement du trouble panique avec agoraphobie (ISBN No. 2-922577-06-6). Montréal, QC: Centre de recherche Fernand-Seguin.
52. Markowitz, J. S., Weissman, M. M., Ouellette, R., Lish, J. D., & Klerman, G. L. (1989). Quality of life in panic disorder. Archives of General Psychiatry, 46, 984-992.
53. Marks, I. M. (1995). Advances in behavioral-cognitive therapy of social phobia. Journal of Clinical Psychiatry, 56(5), 25-31.
54. Marks, I. M., Lovell, K., Noshirvani, H., Livanou, M., & Thrasher, S. (1998). Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: A controlled study. Archives of General Psychiatry, 55, 317-325.
55. Massion, A. O., Warshaw, M. G., & Keller, M. B. (1993). Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. American Journal of Psychiatry, 150, 600-607.
56. Ministère de la santé de l'Ontario (1994). Ontario Health Survey 1990: Mental Health Supplement. Toronto, ON: Ministère de la santé de l'Ontario.
57. Mumford, E., Schlesinger, H. J., Glass, G. V., Patrick, C., & Cuerdon, T. (1984). A new look at evidence about reduced cost of medical utilization following mental health treatment. American Journal of Psychiatry, 141, 1145-1158.
58. Newman, M. G., Kenardy, J., Herman, S., & Taylor, C. B. (1997). Comparison of palmtop-computer-assisted brief cognitive-behavioral treatment to cognitive-behavioral treatment for panic disorder. Journal of Consulting and Clinical Psychology, 65, 178-183.
59. Ninan, P. T. (2001). Dissolving the burden of generalized anxiety disorder. Journal of Clinical Psychiatry, 62(19), 5-10.
60. O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: A controlled study. Canadian Journal of Psychiatry, 44, 64-71.
61. Office canadien de coordination de l'évaluation des technologies de la santé (1997). Lignes directrices pour l'évaluation économique des produits pharmaceutiques: Canada. Ottawa, ON: Auteur.
62. Olfson, M., Sing, M., & Schlesinger, H. J. (1999). Mental health/medical care cost offsets: Opportunities for managed care. Health Affairs, 18, 79-90.
63. Öst, L.-G. (1996). Long term effects of behavior therapy for specific phobias. Dans M. R. Mavissakalian & R. F. Prien (Éds.), Long term treatments of the anxiety disorders. Washington, DC: American Psychiatric Press.
64. O'Sullivan, G., Noshirvani, H., Marks, I., Monteiro, W., & Lelliott, P. (1991). Six-year follow-up after exposure and clomipramine therapy for obsessive-compulsive disorder. Journal of Clinical Psychiatry, 52, 150-155.
65. Otto, M. W., Penava, S. J., Pollack, R. A., & Smoller, J. W. (1996). Cognitive-behavioral and pharmacological perspectives on the treatment or posttraumatic stress disorder. Dans M. H. Pollack, M. W. Otto & J. F. Rosenbaum (Éds.), Challenges in clinical practive: Pharmacological and psychosocial strategies. New York: Guilford Press.
66. Otto, M. W., Pollack, M. H., & Maki, K. M. (2000). Empirically supported treatments for panic disorder: Costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology, 68, 556-563.
67. Power, K. G., Simpson, R. J., Swanson, V., Wallace, L. A., Feistner, A. T. C., & Sharp, D. (1990). A controlled comparison of cognitive-behaviour therapy, diazepam, and placebo, alone or in combination, for the treatment of generalised anxiety disorder. Journal of Anxiety Disorders, 4, 267-292.
68. Radomsky, A. S., & Otto, M. W. (2001). Cognitive-behavioral therapy for social anxiety disorder. Psychiatric Clinics of North America, 24, 805-815.
69. Rees, C. S., Richards, J. C., & Smith, L. M. (1998). Medical utilisation and costs in panic disorder: A comparison with social phobia. Journal of Anxiety Disorders, 12, 421-435.
70. Regier, D. A., Rae, D. S., Narrow, W. E., Kaelber, C. T., & Schatzberg, A. F. (1998). Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of Psychiatry, 34, 24-28.
71. Rice, D. P., & Miller, L. S. (1998). Health economics and cost implications of anxiety and other mental disorders in the United States. British Journal of Psychiatry, 173(54), 4-9.
72. Robins, L. N., Helzer, J. E., Weissman, M. M., Orvaschel, H., Gruenberg, E., Burke, J. D., et al. (1984). Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry, 41, 949-958.
73. Roemer, L., Orsillo, S. M., & Barlow, D. H. (2002). Generalized Anxiety Disorder. Dans D. H. Barlow (Éd.), Anxiety and its disorders: The nature and treatment of anxiety and panic (2e éd.) (p. 477-515). New York: Guilford.
74. Roth, A., & Fonagy, P. (1996). What works for whom: A critical review of psychotherapy research. New York: Guilford.
75. Salvador-Carulla, L., Segui, J., Fernandez-Cano, P., & Canet, J. (1995). Costs and offset effect in panic disorders. British Journal of Psychiatry, 166(27), 23-28.
76. Schneier, F. R., Heckelman, L. R., Garfinkel, R., Campeas, R., Fallon, B. A., Gitow, A., et al. (1994). Functional impairment in social phobia. Journal of Clinical Psychiatry, 55, 322-331.
77. Schneier, F. R., Johnson, J., Hornig, C. D., Liebowitz, M. R., & Weissman, M. M. (1992). Social phobia: Comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry, 49, 282-288.
78. Shear, M. K., & Beidel, D. C. (1998). Psychotherapy in the overall management strategy for social anxiety disorder. Journal of Clinical Psychiatry, 59(17), 39-46.
79. Sherman, J. J. (1998). Effects of psychotherapeutic treatments for PTSD: A meta-analysis of controlled clinical trials. Journal of Traumatic Stress, 11, 413-435.
80. Siegel, L., Jones, W. C., & Wilson, J. O. (1990). Economic and life consequences experienced by a group of individuals with panic disorder. Journal of Anxiety Disorders, 4, 201-211.
81. Simon, G., Ormel, J., Von Korff, M., & Barlow, W. (1995). Health care associated with depressive and anxiety disorders in primary care. American Journal of Psychiatry, 152, 352-357.
82. Souêtre, E., Lozet, H., Cimarosti, I., Martin, P., Chignon, J. M., Adès, J., et al. (1994). Cost of anxiety disorders: Impact of comorbidity. Journal of Psychosomatic Research, 38(1), 151-160.
83. Stahl, S. M., & Soefje, S. (1995). Panic attacks and panic disorder: The great neurologic imposters. Seminars In Neurology, 15, 126-132.
84. Swinson, R. P., Cox, B. J., Kerr, S. A., Kuch, K., & Fergus, K. D. (1992). A survey of anxiety disorders clinics in Canadian hospitals. Canadian Journal of Psychiatry, 37, 188-191.
85. Swinson, R. P., Cox, B. J., & Woszczyna, C. B. (1992). Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. Canadian Medical Assodation Journal, 147, 878-883.
86. Thorn, A., Sartory, G., & Jöhren, P. (2000). Comparison between one-session psychological treatment and benzodiazepine in dental phobia. Journal of Consulting and Clinical Psychology, 68, 378-387.
87. Üstün, T. B., & Sartorius, N. (1993). Public health aspects of anxiety and depressive disorders. International Clinical Psychopharmacology, 8(1), 15-20.
88. Van Balkom, A. J., Bakker, A., Spinhoven, P., Blaauw, B. M., Smeenk, S., & Ruesink, B. (1997). A meta-analysis of the treatment of panic disorder with or without agoraphobia: A comparison of psychopharmacological, cognitive-behavioral, and combination treatments. Journal of Nervous and Mental Disease, 185, 510-516.
89. Van Balkom, A. J., Van Oppen, P., Vermeulen, A. W., Van Dyck, R., Nauta, M. C. E., & Vorst, H. C. M. (1994). A meta-analysis on the treatment of obsessive-compulsive disorder: A comparaison of antidepressants, behavior, and cognitive therapy. Clinical Psychology Review, 14, 359-381.
90. Van der Kolk, B. A., Dreyfuss, D., Michaels, M., Shera, D., Berkowitz, R., Fisler, R., & al. (1994). Fluoxetine in posttraumatic stress disorder. Journal of Clinical Psychiatry, 55, 517-522.
91. Van Etten, M. L., & Taylor, S. (1998). Comparative efficacy of treatments for posttraumatic stress disorder: A meta-analysis. Clinical Psychology and Psychotherapy, 5, 126-144.
92. Van Noppen, B., Steketee, G., McCorkle, B. H., & Pato, M. (1997). Group and multifamily behavioral treatment for obsessive compulsive disorder: A pilot study. Journal of Anxiety Disorders, 11, 431-446.
93. Von Korff, M., Katon, W., & Lin, E. (1990). Psychological distress, physical symptoms, utilization and the cost-offset effect. Dans N. Sartorius, D. Goldberg, G. de Girolamo, J. A. Costa e Silva, Y. Lecrubier & H. -U. Wittchen (Éds), Psychological disorders in general medical settings (p. 159-169). Toronto, ON: Hogrefe & Huber.
94. Wolfe, B. E., & Maser, J. D. (1994). Treatment of panic disorder: A consensus development conference. Washington, DC: American Psychiatric Press.
95. Wittchen, H. -U. (1998). Recognition and management of anxiety syndromes. British Journal of Psychiatry, 173(34), 1-3.
96. Wittchen, H. -U., & Beloch, E. (1996). The impact of social phobia on quality of life. International Clinical Psychopharmacology, 11(3), 15-23.
97. Zatzick, D. F., Marmar, C. R., Weiss, D. S., Browner, W. S., Metzler, T. J., Golding, J. M., et al. (1997). Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sam ple of male Vietnam veterans. American Journal of Psychiatry, 154, 1690-1695.